Johnson & Johnson stock targets $235 resistance with projected further upside: weekly review

Traders Union
All News
Financial News
Johnson & Johnson rises 3.28% this week

Highlights

Johnson & Johnson shows strong medium- and long-term bullish momentum, despite short-term seller pressure below the 20-week moving average.
Price surged 3.28% last week, closing at the weekly high and forming a potential consolidation zone between $221.30 and $235.00.
Key technical indicators signal an upside bias with 75% probability for gains, while mixed signals hint at underlying market indecision.

Product launch and investor activity shape sentiment this week

Johnson & Johnson has launched its Shockwave C2 Aero Coronary IVL Catheter, expanding its interventional cardiology portfolio in the U.S. and Japan. This rollout represents a notable expansion in the treatment of calcified coronary artery disease. The period also saw some institutional investors slightly trim their holdings in JNJ, while the company remains a significant component in major ETFs.

Mixed technical momentum as short-term pressure meets longer-term support

Weekly technical signals for JNJ remain mixed. The price is positioned below the MA-20, indicating some short-term selling pressure, but is supported by the MA-50 and MA-200, which reinforces medium- and long-term bullish momentum. Weekly MACD (Strong Buy) and ADX (Buy) are both positive, while Stochastic RSI and Bull/Bear Power point to seller exhaustion. RSI issues a Buy signal, with Awesome Oscillator and CCI both neutral, pointing to an environment where trend-following indicators remain strong against a backdrop of mean-reverting caution.

Upside bias in coming week amid breakout and pullback risks

Over the next 5 trading days, JNJ is projected to trade within a $221.30 to $235.00 range. Three out of four key weekly indicators suggest a 75% probability for further upside, with a baseline scenario of price stabilization at higher levels. A breakout above $235.00 supports a potential move toward yearly highs, while a drop below $221.30 may trigger a corrective pullback to the MA-50 near $200.89.

Earlier, analysts noted that Johnson & Johnson was demonstrating underlying bullish momentum despite short-term technical headwinds. With the latest rebound and product expansion, renewed upward momentum improves the near-term outlook, making a sustained move above $235.00 a potential catalyst for testing yearly highs.

Source of Data: JNJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.